These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27134250)

  • 1. The Modified Hand Mobility in Scleroderma Test and Skin Involvement - A Followup Study.
    Sandqvist G; Wuttge DM; Hesselstrand R
    J Rheumatol; 2016 Jul; 43(7):1356-62. PubMed ID: 27134250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis.
    Sandqvist G; Nilsson JÅ; Wuttge DM; Hesselstrand R
    J Rheumatol; 2014 Nov; 41(11):2186-92. PubMed ID: 25274889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.
    Bagnato GL; Roberts WN; Fiorenza A; Arcuri C; Certo R; Trimarchi F; Ruggeri RM; Bagnato GF
    Endocrine; 2016 Feb; 51(2):291-7. PubMed ID: 25994300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis.
    Sandqvist G; Hesselstrand R; Eberhardt K
    Scand J Rheumatol; 2009; 38(4):304-10. PubMed ID: 19296402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.
    Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA;
    Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turkish version of modified Hand Mobility in Scleroderma test: A translation and validation study.
    Kaymaz S; Karasu U; Alkan H; Cobankara V
    Int J Rheum Dis; 2021 Aug; 24(8):1040-1046. PubMed ID: 34159735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker.
    Hesselstrand R; Kassner A; Heinegård D; Saxne T
    Ann Rheum Dis; 2008 Sep; 67(9):1242-8. PubMed ID: 18065498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L; Lunt M; Nihtyanova S; Hoseini M; Silman A; Black CM; Denton CP
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study.
    Hesselstrand R; Carlestam J; Wildt M; Sandqvist G; Andréasson K
    Arthritis Res Ther; 2015 Nov; 17():329. PubMed ID: 26584645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
    Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
    Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
    Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis.
    Kim HB; Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
    Scand J Rheumatol; 2021 May; 50(3):231-238. PubMed ID: 33243053
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
    Khanna D; Clements PJ; Volkmann ER; Wilhalme H; Tseng CH; Furst DE; Roth MD; Distler O; Tashkin DP
    Arthritis Res Ther; 2019 Jan; 21(1):23. PubMed ID: 30651141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.
    Gheita TA; Sayed S; Azkalany GS; Abaza N; Hammam N; Eissa AH
    Clin Rheumatol; 2018 Mar; 37(3):757-763. PubMed ID: 29076114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brazillian version of the hand mobility in scleroderma (HAMIS) test: translation and validation.
    Azevedo PM; Sanson ES; Skare TL; Dos Santos TAFG; Martin P
    Adv Rheumatol; 2019 Nov; 59(1):51. PubMed ID: 31753022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin involvement in scleroderma--where histological and clinical scores meet.
    Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D
    Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
    Wannarong T; Muangchan C
    Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.
    Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA;
    Arthritis Rheumatol; 2018 Nov; 70(11):1829-1834. PubMed ID: 29781588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.